Cognitive-Behavioral and Pharmacological Interventions for Premenstrual Syndrome or Premenstrual Dysphoric Disorder: A Meta-Analysis

  title={Cognitive-Behavioral and Pharmacological Interventions for Premenstrual Syndrome or Premenstrual Dysphoric Disorder: A Meta-Analysis},
  author={Maria Kleinst{\"a}uber and Michael Witth{\"o}ft and Wolfgang Hiller},
  journal={Journal of Clinical Psychology in Medical Settings},
The current meta-analysis investigates the efficacy of psychotherapeutic interventions and psychopharmacotherapy for premenstrual syndrome (PMS) and premenstrual dysphoric disorder. Based on a multiple-phase literature search, controlled trials were selected according to a priori defined inclusion criteria. Data were extracted on the basis of a standardized coding scheme. The standardized weighted mean difference (random effects model) was used as effect size index. Dependent on outcome, 22… 
Internet-Based Cognitive-Behavioural Intervention for Women with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial
The iCBT was highly effective in reducing the burden of PMDD, and it appears to be particularly important to address coping styles and stress management in the treatment.
Effect of psychosocial interventions on the severity of premenstrual syndrome: a meta-analysis
Psychosocial interventions, especially coping skills training for women with PMS, were effective in reducing the severity of PMS; however, needed caution due to the small number of studies.
Reply to “Questioning the Beneficial Effects of Internet-Based Cognitive Behavioral Therapy on Premenstrual Dysphoric Disorder”
The moderator effect of seeking social support as a coping mechanism is rather unlikely to be attributed to a current diagnosis of depression only, because the involved neuronal brain circuits and the exact changes in serotonin metabolism have been different between depression and PMDD.
Internet-based cognitive behavioural self-help for premenstrual syndrome: study protocol for a randomised controlled trial
Evaluating the efficacy of a cognitive behavioural self-help treatment for women suffering from premenstrual syndrome based on cognitive behavioural therapy principles via the internet as a randomised controlled trial.
A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Serotoninergic antidepressants have been established as the first-line treatment option for PMDD; however, there are a variety of additional treatment options that should be considered if a patient fails to achieve an adequate therapeutic response with a selective serotonin reuptake inhibitor.
Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions: A Systematic Review of Therapeutic Options
Based on the results of the qualitative synthesis, the best therapeutic option in the treatment of adult PMDD patients free of other mental disorders are selective serotonin reuptake inhibitor antidepressants and low doses of oral estroprogestins.
Case of a Girl with Irritability and Mood Swings with Her Periods
Using a case-based approach, the importance of using a validated adolescent screening tool in assessment and a stepwise management approach based on symptom severity and functional impairment are highlighted.
Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges
The management of comorbid PMDD/BD needs as a first step to stabilize the bipolar symptoms by means of optimal dosages of mood stabilizers, and in euthymic BD patients, the PMDD symptoms could be treated with estroprogestins.
The effect of a social network-based cognitive behavioral therapy intervention on the severity of premenstrual syndrome symptoms: a protocol of a randomized clinical trial study
It is anticipated that the findings of the present study may demonstrate the effectiveness of the cognitive behavioral therapy intervention on the severity of PMS symptoms that could guide healthcare providers in opting for suitable treatment alternatives for the syndrome.
Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder.
  • Mara Smith, B. Frey
  • Medicine, Psychology
    Journal of psychiatry & neuroscience : JPN
  • 2016
The use of anti-depressants in this population should be restricted to patients in whom PMDD is disabling and is not responsive to hormonal agents, as well as practical, stepwise recommendations for the diagnosis and management of these comorbid conditions.


Psychological Intervention for Premenstrual Syndrome: A Meta-Analysis of Randomized Controlled Trials
Low quality evidence from randomized trials suggests that cognitive behavioural therapy may have important beneficial effects in managing symptoms associated with premenstrual syndrome.
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
The comparison of 2 classes of antidepressants strongly favored the serotonergic drug, which effectively reduced symptoms and improved functioning and was well tolerated by women with severe premenstrual syndrome.
Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Meta-Analysis
A meta- analysis demonstrates that SSRIs are effective for treating PMS and premenstrual dysphoric disorder, with continuous dosing regimens favored for effectiveness.
Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
Serotonin reuptake inhibitors such as sertraline are useful therapeutic options for women with premenstrual dysphoria as reflected by symptomatic improvement and change in reported functional impairment.
Fluoxetine in the Treatment of Premenstrual Dysphoria
Background Premenstrual dysphoria shares certain features with depression and anxiety states, which have been linked to serotonergic dysregulation. We evaluated the efficacy and safety of fluoxetine
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial.
Doses of paroxetine CR doses of 12.5 mg/day and 25 mg/ day are effective in treating PMDD and are well tolerated.
Selective serotonin reuptake inhibitors for premenstrual syndrome.
SSRIs were found to be highly effective in treating premenstrual symptoms and there was no significant difference between trials funded by pharmaceutical companies and those independently funded.
Cognitive therapy for premenstrual syndrome: a controlled trial.
Efficacy of Intermittent, Luteal Phase Sertraline Treatment of Premenstrual Dysphoric Disorder